16 June 2005 / 8.30 -12.30 / Ørestad / Copenhagen / Denmark
From candidate to phase II: How to prepare
- introducing company cases, expert advice and profiles on expert assistance
Get the new publication and read the essence of experience of more than 25 private and public organisations in Medicon Valley!
Programme
8.30 Registration and breakfast
9.00 Presentation of Medicon Valley Drug and Device Development Guide / Stina Gestrelius & Niels Gerner Larsen, Medicon Valley Alliance
9.20 Approaching non-clinical development / Andy Makin, Scantox
9.45 Approaching early clinical development / Poul-Martin Haahr, Medicon
10.10 Cofee Break
10.30 Efficient development - introducing new techniques / Niklas Lindberg, TFS Trial Form Support
10.55 The analytical laboratory in drug development / Yvonne Lech, Capio Diagnostik
11.20 How to facilitate the process from idea to commercialisation in the academic environment / Christer Sjögren, Lund University Hospital
11.45 Experience from Medicon Valley companies (panel discussion) / Invited companies: BioInvent, Gastrotech Pharma, Chempaq, TopoTarget, ProstaLund, Genmab
12.30 Light lunch and networking
Venue
Arne Jacobsens Allé 17
Ørestad City
Copenhagen, Denmark
Time
8.30-12.30
Price (including free copies of Medicon Valley Drug and Device Development Guide)
MVA-members: Free of charge
Non-members: DKK 1000 (ex. VAT)
Registration
Anette Andersson, aa@mva.org
Registration deadline: 14 June 2005
If you want further information, please contact: Niels Gerner Larsen, Medicon Valley Alliance, ngl@mva.org / +45 28 75 41 52 or Stina Gestrelius, Medicon Valley Alliance, sg@mva.org / +46 46 222 1683.